Bayer AG (OTC Pink - Current Information:BAYRY)
| 13.29 Delayed Data As of Sep 17 |  -0.19 / -1.41%Today’s Change | 11.65 Today|||52-Week Range 17.34 | -10.44% Year-to-Date |
Latest BAYRY News | Press Releases
| REGENXBIO (RGNX) Stock Up on Collaboration Deal With AbbVie Sep 14 / Zacks.com - Paid Partner Content | Bayer's (BAYRY) Chronic Cough Candidate Meets Efficacy Goal Sep 07 / Zacks.com - Paid Partner Content |
| Pharma Stock Roundup: SNY to Buy Kadmon, New Approvals for AZN & MRK's Drugs Sep 10 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 13.48 |
| Today’s open | 13.37 |
| Day’s range | 13.21 - 13.39 |
| Volume | 550,853 |
| Average volume (3 months) | 439,135 |
| Market cap | $52.2B |
Data as of 09/17/2021
Growth & Valuation
| Earnings growth (last year) | -361.08% |
| Earnings growth (this year) | -8.29% |
| Earnings growth (next 5 years) | +4.48% |
| Revenue growth (last year) | -3.17% |
| P/E ratio | -- |
| Price/Sales | 1.23 |
| Price/Book | 1.40 |
Competitors
| No competitors data available. |
Financials
| Next reporting date | November 9, 2021 |
| EPS forecast (this quarter) | $0.26 |
| Annual revenue (last year) | $47.2B |
| Annual profit (last year) | -$12.0B |
| Net profit margin | -37.61% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters Leverkusen, Nordrhein-westfalen |
Forecasts
Chart unavailable
